Here-presented evidence, thus, further suggests that preconception assessments of CRP, a widely available and low-cost blood test, may in infertile women be useful in identifying those at increased risk for immune system-induced miscarriages which, in turn, may allow for timely pharmaceutical interventions. The gene discussed is CRP; the disease is Infertility.